Cargando…
Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia
Relapse after chemotherapy and hematopoietic stem cell transplantation leads to adverse prognosis for acute myeloid leukemia (AML) patients. As a “conditionally essential amino acid,” glutamine contributes to the growth and proliferation of AML cells. Glutamine-target strategies as new treatment app...
Autores principales: | Xiao, Yan, Hu, Bingbing, Guo, Yao, Zhang, Dengyang, Zhao, Yuming, Chen, Yun, Li, Na, Yu, Liuting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356674/ https://www.ncbi.nlm.nih.gov/pubmed/37249801 http://dx.doi.org/10.1007/s11864-023-01104-0 |
Ejemplares similares
-
The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia
por: Zhuang, Xiaomei, et al.
Publicado: (2022) -
Expression of a recombinant FLT3 ligand and its emtansine conjugate as a therapeutic candidate against acute myeloid leukemia cells with FLT3 expression
por: Zhang, Dengyang, et al.
Publicado: (2021) -
Reductive carboxylation of glutamine as a potential target in acute myeloid leukemia
por: Roma, Alessia, et al.
Publicado: (2023) -
Targeting glutamine metabolism as a therapeutic strategy for cancer
por: Jin, Jonghwa, et al.
Publicado: (2023) -
Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia
por: Chapuis, Nicolas, et al.
Publicado: (2019)